IJMS SJR and Scopus Metrics: What They Actually Mean
IJMS has real visibility and indexing strength, but the live decision is whether you want the speed and reach enough to accept the MDPI trade-offs.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
International Journal of Molecular Sciences at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- International Journal of Molecular Sciences's scope and readership determine whether the journal is a useful target.
- Scope specificity matters more than headline metrics for most manuscript decisions.
- Manusights has not verified a current acceptance rate for International Journal of Molecular Sciences. Check the publisher source for current data; this does not mean the publisher reports none.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
- If timeline matters: International Journal of Molecular Sciences takes 17.5 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs CHF 2900. Check institutional agreements before submitting.
Quick answer: International Journal of Molecular Sciences has a real Scopus profile, but the right read is visibility and volume rather than top-end prestige. Current Scopus-based sources place it at SJR 1.273, impact score 5.03, global rank 3199, and h-index 314 in 2024.
MDPI's journal page also reports CiteScore 10.0 and a first decision approximately 17.5 days after submission (median values for papers published in the first half of 2026). That confirms real discoverability and operational speed. The useful submission question is whether that package is what you actually want.
Direct answer
If your question is whether IJMS is a legitimate, visible journal under Scopus metrics, the answer is yes.
Metric | Current value | What it tells you |
|---|---|---|
SJR | 1.273 | prestige-weighted influence is real but not flagship-level |
Impact Score | 5.03 | citation density is solid for a high-volume journal |
Global rank | 3199 | this is visible and established, but not top-tier prestige |
h-index | 314 | the archive has substantial accumulated reuse |
Best quartile | Q1 | the journal still lands in top-quartile views overall |
Coverage history | 2000-2025 | this is not a transient indexing artifact |
That profile matters because it confirms a real journal with real usage. It does not turn IJMS into a molecular-biology prestige flagship.
Overview
The useful summary is that IJMS sells three things clearly: speed, reach, and indexing. The part authors often blur is whether that package is worth the reputation trade-off relative to stronger society journals or more selective field journals.
What changed in 2024
The 2024 picture is a mild strengthening year on SJR and a flat year on impact score.
- SJR moved up from 1.179 in 2023 to 1.273 in 2024
- impact score moved up slightly from 5.00 to 5.03
- global rank improved from 3393 to 3199
That means the journal's Scopus standing improved modestly, but not in a way that changes its underlying editorial identity. It is still a high-volume MDPI journal with real visibility rather than a scarcity-driven prestige room.
Ten-year SJR and Scopus trend
Year | SJR | Impact Score | Global Rank |
|---|---|---|---|
2024 | 1.273 | 5.03 | 3199 |
2023 | 1.179 | 5.00 | 3393 |
2022 | 1.154 | 5.57 | 3296 |
2021 | 1.176 | 6.03 | 3161 |
2020 | 1.455 | 5.62 | 2384 |
2019 | 1.317 | 4.74 | 2808 |
2018 | 1.312 | 4.41 | 2852 |
2017 | 1.260 | 3.97 | 3077 |
2016 | 1.235 | 3.61 | 3206 |
2015 | 1.157 | 3.76 | 3597 |
2014 | 0.991 | 3.37 | 4396 |
The trend shows a journal that climbed into a stable, respectable Q1-ish visibility zone and then largely stayed there. This is not a journal with elite prestige concentration. It is a journal with persistent reach.
What the trend means in practice
For authors, the trend usually means:
- the journal is not weak or obscure
- the Q1 signal is real, but easy to overread
- the main advantages are speed and visibility rather than exclusivity
- the main risk is not citation invisibility, but field perception
That is why the metrics help. They prevent authors from underselling the journal's discoverability while also preventing them from mistaking that discoverability for top-end prestige.
How IJMS compares with realistic neighbors
Journal | 2024 SJR | What the metric profile usually signals |
|---|---|---|
International Journal of Molecular Sciences | 1.273 | high-volume molecular-science journal with real indexing strength |
PLOS ONE | 0.803 | broader soundness-first megajournal with weaker field signaling |
Scientific Reports | 0.874 | broad Nature Portfolio journal with similar discoverability logic |
Molecular Cell | 9.051 | elite specialist journal on an entirely different prestige tier |
This is the useful comparison. IJMS is a legitimate publishing option with reach, but not a substitute for stronger specialist titles when prestige and selectivity are the main goal.
What editors are really screening for
MDPI's own journal page frames IJMS as a broad molecular-sciences forum spanning biochemistry, molecular and cell biology, molecular medicine, and chemistry. The same page emphasizes a first decision approximately 17.5 days after submission, which tells you something operationally important: the product is built around throughput and fast handling.
In practice, that means the journal usually screens for:
- scope fit across a very broad molecular-science umbrella
- technical completeness
- clear presentation and a manuscript package ready for rapid handling
- work that benefits from open-access distribution and broad subject indexing
That is a real editorial screen. It is just a different screen from what top society or flagship journals are selling.
What we see in IJMS Metric Questions
For IJMS metric questions, three mistakes recur.
The Q1-overread mistake. Authors often treat a Q1 label as if it means top-field prestige. Here it usually means strong indexing plus broad category coverage.
The speed-substitution mistake. Another common miss is using fast decision time as a substitute for deciding what journal signal the paper actually needs.
The field-perception mistake. We also see teams skip a real discussion about how their subfield reads MDPI. The metrics do not erase that culture-level question.
That is the practical meaning of the profile. IJMS is strong enough to be a serious option, but still a strategic trade-off.
What these metrics mean for authors
For authors, the current profile says:
- the journal is visible and index-legible
- accepted papers are likely to be found and cited
- the biggest advantages are operational, not prestige-based
- the main decision is whether speed and reach matter more than exclusivity
The h-index of 314 matters because it reflects a large archive with real ongoing reuse. That is enough to matter in many institutional environments even if the journal is not culturally premium in every field.
A quick IJMS fit benchmark
Before you let the Q1 label do too much work, run a short benchmark on the manuscript itself.
Benchmark question | Why it matters at IJMS |
|---|---|
Does the paper need fast handling and broad open-access distribution? | That is one of the journal's clearest strengths. |
Is the field likely to value indexing and visibility more than scarcity? | Different communities read the same metrics very differently. |
Would a stronger specialist journal offer a better prestige signal? | This is usually the real alternative, not invisibility. |
Is the manuscript polished enough for a fast operational workflow? | Speed helps only if the paper is already ready. |
That benchmark is more useful than staring at quartiles. If the manuscript fails the prestige-fit test for your field, the SJR does not solve that.
Submit If / Think Twice If
Submit if:
- you want fast editorial handling
- broad indexing and open access are major priorities
- the field will respect the journal enough for this paper's purpose
- the manuscript is complete and ready for a rapid workflow
Think twice if:
- the paper needs a stronger prestige signal than the journal normally carries
- your subfield is likely to discount the MDPI venue choice heavily
- the real goal is selectivity rather than visibility
- the manuscript would likely land better in a more focused journal
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What should drive the decision after the metrics check
The better question is whether you want the IJMS trade-off for this manuscript.
That is why the next useful reads are:
If you want speed, indexing, and broad discoverability, the current metrics support the choice. If the paper mainly needs stronger editorial scarcity, the metric profile is telling you not to overread the Q1 label. An IJMS submission readiness check is a direct way to pressure-test that before submission.
Practical verdict
IJMS has a real Scopus profile and remains a legitimate, visible molecular-science publishing option. The 2024 numbers confirm reach, not flagship prestige.
For authors, the metric question is mostly solved. The live question is whether the journal's speed-and-visibility trade-off is the right one for this paper.
- International Journal of Molecular Sciences JIF, Manusights.
Frequently asked questions
International Journal of Molecular Sciences' 2024 SJR is 1.273 on current Scopus-based metric aggregators, which keeps it in Q1 overall despite weaker standing in some narrower categories.
Current Scopus-based sources place IJMS' 2024 impact score at 5.03, with a global rank of 3199 and h-index of 314.
Because IJMS is indexed across several broad category views and has substantial volume and citation reach, even though that does not make it a flagship molecular-biology prestige journal.
No. The real question is whether the manuscript benefits more from speed, broad indexing, and open access than from a stricter editorial scarcity signal.
Sources
- 1. International Journal of Molecular Sciences metrics page, Resurchify.
- 2. International Journal of Molecular Sciences journal page, MDPI.
- 3. IJMS aims and scope, MDPI.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Choose the practical next step for your research.
Start with the question in front of you, or use the guided learning path when you want a clearer view of the full publishing process.
Where to go next
Same journal, next question
- IJMS MDPI Submission Guide: Requirements, Formatting and What Editors Want
- How to Avoid Desk Rejection at International Journal of Molecular Sciences in 2026
- Is International Journal of Molecular Sciences a Good Journal? Fit Verdict
- Rejected from International Journal of Molecular Sciences? The 6 Best Journals to Submit Next
- International Journal of Molecular Sciences Submission Process
- International Journal of Molecular Sciences Review Time 2026: Time to First Decision and Publication